Esperion Therapeutics

3 Small Biotech Stocks Being Run by Proven Winners
3 Small Biotech Stocks Being Run by Proven Winners
Motley Fool
biotech
Axovant
Esperion Therapeutics
Aurinia Pharmaceuticals
Richard Glickman
David Hung
Roger Newton
Flag link:
3 Best Biotech Stocks During Trump's First 100 Days
3 Best Biotech Stocks During Trump's First 100 Days
Motley Fool
biotech stocks
Donald Trump
Esperion Therapeutics
Aurinia Pharmaceuticals
TG Therapeutics
Flag link:
Could Pfizer Buy Esperion Therapeutics?
Could Pfizer Buy Esperion Therapeutics?
Motley Fool
Pfizer
Esperion Therapeutics
M&A
bococizumab
Flag link:
Esperion Therapeutics Sees Clear FDA Path For Its Heart Drug
Esperion Therapeutics Sees Clear FDA Path For Its Heart Drug
Forbes
Esperion Therapeutics
FDA
bempadoic acid
heart disease
heart attacks
Flag link:
Amgen Blew It…For Medicines Co., Esperion Too
Amgen Blew It…For Medicines Co., Esperion Too
Barron's
Amgen
Medicines Company
Esperion Therapeutics
Repatha
inclisiran
Flag link:
Biotechs Breaking Out On Drug Development News
Biotechs Breaking Out On Drug Development News
Forbes
Bluebird Bio
Esperion Therapeutics
Amicus Therapeutics
Kite Pharma
Flag link:
Esperion Falls on Regulatory Setback for Cholesterol-Lowering Pill
Esperion Falls on Regulatory Setback for Cholesterol-Lowering Pill
TheStreet.com
Esperion Therapeutics
LDL-C
ETC-1002
Flag link:
Amgen's Acquisition Of Dezima And CETP Drug Like Pfizer's '03 Buy Of Esperion. Will History Repeat?
Amgen's Acquisition Of Dezima And CETP Drug Like Pfizer's '03 Buy Of Esperion. Will History Repeat?
Forbes
Amgen
Dezima
CETP inhibitors
Pfizer
M&A
Esperion Therapeutics
Flag link:
Esperion surges after FDA offers a shot at quick approval for LDL-lowering drug
Esperion surges after FDA offers a shot at quick approval for LDL-lowering drug
Fierce Biotech
FDA
Esperion Therapeutics
LDL cholesterol
ETC-1002
Flag link:
Why Regeneron’s Approval is Bad News For Esperion Therapeutics
Why Regeneron’s Approval is Bad News For Esperion Therapeutics
Barron's
Regeneron
Esperion Therapeutics
Sanofi
Praluent
Amgen
Repatha
ETC-1002
Flag link:
The FDA Breathes New Life Into Esperion's ETC-1002
The FDA Breathes New Life Into Esperion's ETC-1002
Motley Fool
FDA
Esperion Therapeutics
ETC-1002
Flag link:
5 Biotech Stocks On Deck With The FDA
5 Biotech Stocks On Deck With The FDA
Yahoo/Benzinga
FDA
Alnylam
Patisiran
Esperion Therapeutics
ETC-1002
Intercept Pharmaceuticals
obeticholic acid
Sarepta Therapeutics
eteplirsen
Tekmira
TKM-PLK1
Flag link:
7 Biotech Stocks Moving Off The UBS Healthcare Conference
7 Biotech Stocks Moving Off The UBS Healthcare Conference
Yahoo/Benzinga
biotech
UBS
AcelRx
Affirmed NV
Atara
Cerulean Pharma
Endo International
Esperion Therapeutics
Immune Design
Flag link:
Why These 2 Biotechs May Be Bought Out Soon
Why These 2 Biotechs May Be Bought Out Soon
24/7 Wall St
Esperion Therapeutics
Ariad Pharmaceuticals
Flag link:
1 Tiny Biotech's Blockbuster Opportunity in Heart Disease
1 Tiny Biotech's Blockbuster Opportunity in Heart Disease
Motley Fool
ETC-1002
heart disease
Esperion Therapeutics
Flag link:
Esperion shares rally on cholesterol drug study results
Esperion shares rally on cholesterol drug study results
Marketwatch
Esperion Therapeutics
ETC-1002
Merck
Zetia
Flag link:
Small Esperion Vs Pharma Giants In The Cholesterol Race
Small Esperion Vs Pharma Giants In The Cholesterol Race
Seeking Alpha
Esperion Therapeutics
ETC-1002
Sanofi
Regeneron
Amgen
Pfizer
Roche
Flag link:
Esperion's drug lowers blood fat in mid-stage study
Esperion's drug lowers blood fat in mid-stage study
Reuters
Esperion Therapeutics
ETC-1002
Flag link:
Editorials: In praise of an unsinkable biotech business
Editorials: In praise of an unsinkable biotech business
Mlive
Esperion Therapeutics
HDL therapy
Flag link: